Teplizumab: The First Treatment to Delay the Progression of Type 1 Diabetes-Reference-Cited by-同舟云学术

Teplizumab: The First Treatment to Delay the Progression of Type 1 Diabetes

Published:2023-05-16 Issue:3 Volume:41 Page:474-476
ISSN:0891-8929
Container-title:Clinical Diabetes
language:en
Short-container-title:

Author:

Goldman Jennifer D.¹^ORCID,Choi Hailey¹

Affiliation:

1. Massachusetts College of Pharmacy and Health Sciences, Boston, MA

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/clinical/article-pdf/41/3/474/729106/diaclincd230033.pdf

Reference9 articles.

1. 2. Classification and diagnosis of diabetes: Standards of Care in Diabetes—2023;ElSayed;Diabetes Care,2023

2. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association;Insel;Diabetes Care,2015

3. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study;Rawshani;Lancet,2018

4. U.S. Food and Drug Administration . FDA approves first drug that can delay onset of type 1 diabetes. Available from https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-can-delay-onset-type-1-diabetes. Accessed 19 March 2023

5. ISPAD Clinical Practice Consensus Guidelines 2018: Stages of type 1 diabetes in children and adolescents;Couper;Pediatr Diabetes,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An orally available cancer drug AZD6738 prevents type 1 diabetes;Frontiers in Immunology;2023-12-18